| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10072-016-2727-2 |
| P698 | PubMed publication ID | 27761842 |
| P2093 | author name string | Ying Shao | |
| Xuan Chen | |||
| Haoyuan Yin | |||
| P2860 | cites work | Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. | Q55475249 |
| Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma | Q83170873 | ||
| Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas | Q83532352 | ||
| Global cancer statistics | Q22241238 | ||
| Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma | Q24632791 | ||
| Crystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesion | Q27650414 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| The epidemiology of glioma in adults: a "state of the science" review | Q28387839 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation | Q33675114 | ||
| Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma | Q34113523 | ||
| Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma | Q34271830 | ||
| Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme | Q34587527 | ||
| High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q34620657 | ||
| Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells | Q35762947 | ||
| Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression | Q36515358 | ||
| Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets | Q36544108 | ||
| GSK-3β regulates tumor growth and angiogenesis in human glioma cells | Q36544729 | ||
| MiR-106a is an independent prognostic marker in patients with glioblastoma | Q36865988 | ||
| Biology of angiogenesis and invasion in glioma | Q37533625 | ||
| CD147/basigin promotes progression of malignant melanoma and other cancers | Q37671094 | ||
| Cancer-related issues of CD147. | Q37765372 | ||
| GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity | Q38197021 | ||
| Glioma biology and molecular markers | Q38281875 | ||
| The roles of CD147 in the progression of gliomas | Q38594492 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression | Q38862889 | ||
| Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo | Q39212676 | ||
| Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis | Q40406438 | ||
| Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. | Q40585451 | ||
| CD147, MMP9 expression and clinical significance of basal-like breast cancer | Q42518788 | ||
| Neuro-oncology, a decade of temozolomide and beyond | Q42809906 | ||
| Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma | Q43137955 | ||
| Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas | Q48923618 | ||
| Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma. | Q55463284 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 129-136 | |
| P577 | publication date | 2016-10-19 | |
| P1433 | published in | Neurological Sciences | Q15763262 |
| P1476 | title | The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma | |
| P478 | volume | 38 |
| Q47402442 | Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease |
| Q48049656 | Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. |
| Q57056183 | Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression |
| Q90255815 | Enhanced glucose metabolism mediated by CD147 is associated with 18 F-FDG PET/CT imaging in lung adenocarcinoma |
| Q64052645 | Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma |
| Q64108170 | Shikonin inhibits proliferation and induces apoptosis in glioma cells via downregulation of CD147 |
| Q49571186 | Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma |
| Q94594144 | The Combination of CD147 and MMP-9 Serum Levels Is Identified as Novel Chemotherapy Response Markers of Advanced Non-Small-Cell Lung Cancer |
Search more.